According to 36Kr.com, ForceClouds, a cloud solution provider targeting the field of life sciences, has completed a $10 million Series B financing, led by Eight Roads, with participation from Anshun Fuhai High-Tech Venture Capital and Blue Lake Capital. Hu Junping, President of ForceClouds, said the proceeds of this financing would mainly be used for product research and development.
ForceClouds is specialized in using cloud computing, big data and artificial intelligence technology to provide cloud solutions of information management for pharmaceutical, CRO, medical equipment, animal health, crop science, nutrition and healthcare companies, hospitals and so on. At present, ForceClouds has cooperated with nearly 100 enterprises, including AstraZeneca, Bayer, MSD, ThermoFisher, B. Braun, bioMerieux and other large multinational pharmaceutical enterprises, as well as Hengrui Medical, Hansoh Pharma, and other Chinese leading enterprises.
Focusing on the three aspects including marketing, clinical trial and new drug research and development of pharmaceutical enterprises, ForceClouds has developed three kinds of products, respectively for sales management, clinical trial, and big data with artificial intelligence.
SFEpower, the one-stop sales efficiency management platform of ForceClouds, helps pharmaceutical enterprises improve the efficiency of sales management in marketing and commercialization, to catch the need of customers more effectively and accurately. VirgoClinical, a software for drug discovery and clinical trial management, provides systematic services of clinical trials to pharmaceutical companies, hospitals, and CRO companies, helping them ensure compliance with clinical trial data management standards, improve the quality of data and help companies reduce development costs. In general, ForceClouds, which started with sales management, has been gradually transformed into a provider of whole-process solutions covering pharmaceutical research and development, clinical trials, and sales.
About Eight Roads
Eight Roads is committed to supporting entrepreneurs as they scale their businesses. The company not only invests in businesses through its own funds, but also makes direct investments and identify themes and talented teams to start businesses from scratch. In the past 10 years alone, Eight Roads has invested almost $6 billion into growing companies in technology and healthcare.
About Blue Lake Capital
As a next-generation, research-driven venture capital firm, Blue Lake Capital primarily invests in emerging industries that are transforming from traditional industry models to upgraded, high-tech innovative model. The company focuses on early-stage start-ups in the following sectors; enterprise software and service, consumer internet and smart manufacturing.
Blue Lake Capital manages funds denominated in USD and RMB. Leveraging its network of successful entrepreneurs and its extensive experience, Blue Lake Capital supports the growth of companies into market leaders.